The estimated Net Worth of Thomas J. Errico is at least $1.4 Milione dollars as of 15 August 2024. Thomas Errico owns over 5,000 units of ElectroCore Inc stock worth over $1,402,908 and over the last 5 years he sold ECOR stock worth over $0. In addition, he makes $0 as Independent Director at ElectroCore Inc.
Thomas has made over 10 trades of the ElectroCore Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of ECOR stock worth $30,600 on 15 August 2024.
The largest trade he's ever made was buying 176,470 units of ElectroCore Inc stock on 14 April 2020 worth over $150,000. On average, Thomas trades about 28,316 units every 105 days since 2019. As of 15 August 2024 he still owns at least 233,818 units of ElectroCore Inc stock.
You can see the complete history of Thomas Errico stock trades at the bottom of the page.
Dr. Thomas J. Errico M.D. serves as Independent Director of the Company. He served as the Chief, Division of Spine Surgery in Orthopedics, NYU Langone Health from 1997 until 2019. He is also currently Adjunct Professor, Department of Orthopaedic Surgery in the NYU Grossman School of Medicine. In addition, Dr. Errico is a member of the International Society for the Advancement of Spine Surgery, and served as its President from 2010 to 2011. He is also an original member of the North American Spine Society, and served as its President from 2003 to 2004. Dr. Errico has founded multiple companies in the healthcare industry, including Spinecore, Inc. in 2002, where he served as a director until it was sold to Stryker, Inc. in 2004. Dr. Errico was also a founding member of K2M Group Holdings, Inc. in January 2004. Dr. Errico holds a B.S. in Zoology from Rutgers University and an M.D. from Rutgers Medical School, formerly the University of Medicine and Dentistry of New Jersey. The Board believes Dr. Errico is qualified to serve on the Board due to his long tenure as a practicing spine-surgeon and his leadership role with a world-class medical institution, as well as serving as a co-founder, director and investor in a number of successful early stage healthcare companies.
Thomas Errico is 68, he's been the Independent Director of ElectroCore Inc since . There are 1 older and 16 younger executives at ElectroCore Inc. The oldest executive at ElectroCore Inc is Peter Cuneo, 76, who is the Independent Director.
Thomas's mailing address filed with the SEC is 200 FORGE WAY, SUITE 205, , ROCKAWAY, NJ, 07866.
Over the last 6 years, insiders at ElectroCore Inc have traded over $541,551 worth of ElectroCore Inc stock and bought 3,996,513 units worth $5,852,816 . The most active insiders traders include James L L Tullis, Joseph P Errico e Thomas J. Errico. On average, ElectroCore Inc executives and independent directors trade stock every 38 days with the average trade being worth of $422,718. The most recent stock trade was executed by Thomas J. Errico on 15 August 2024, trading 5,000 units of ECOR stock currently worth $30,600.
electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.
ElectroCore Inc executives and other stock owners filed with the SEC include: